Lantern Pharma

Lantern Pharma Subsidiary Starlight Therapeutics Names New Chief Medical Officer to Oversee Clinical Trials

by | Jan 19, 2024

Marc Chamberlain, M.D., has been appointed as the Chief Medical Officer at Starlight Therapeutics.

Starlight Therapeutics is a Dallas-based Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options.

In his role as CMO, Chamberlain will oversee the company’s upcoming clinical trials focused on several serious and complex brain-related conditions: glioblastoma and other high-grade gliomas (aggressive types of brain tumor), brain metastases in adults (secondary brain tumors originating from cancer elsewhere in the body), and two types of pediatric brain tumors — atypical teratoid rhabdoid tumors (ATRT) and diffuse intrinsic pontine glioma (DIPG)....

MORE
Busting the Brain’s Firewall: How Lantern Pharma’s Algorithms Can Predict a Drug’s Ability to Reach the Brain
by | May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
MORE
Lantern Pharma Adds VP of Clinical Development, Additional Team Members
by | Mar 2, 2023

Dallas-based Lantern Pharma Inc. has expanded its clinical development team with the addition of Dr. Reggie Ewesuedo as vice president of clinical development, and several additional team members....

MORE
16 Biotech Companies in Dallas-Fort Worth ‘Putting the Tech in Bio’ to Drive Breakthroughs

Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....

MORE

Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO

by | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas. Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE
Meet the Finalists: The Innovation Awards 2022, Presented by Dallas Innovates and D CEO
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE
6 Dallas Innovators You Need to Know Today—and Why
by | Sep 2, 2021
Sally Beauty tapped its first-ever female CEO, NTT DATA gets a digital transformation leader, and more senior leadership moves this week.
MORE
Lantern Pharma CEO Shares His Four Secrets to Turning a Startup into an IPO
by | Aug 3, 2021
Panna Sharma has had a hand in four IPOs. The latest was finalized during the middle of COVID for his clinical stage biopharmaceutical oncology firm, Lantern Pharma. Now, he shares the phases to transforming a young private company into the next public success story.
MORE
urban air

DI People: Lantern Pharma, The Richards Group, and RKD Announce Leadership Moves

by | Dec 17, 2019
In this weekly roundup of executive and leadership moves by companies and organizations in North Texas, you'll also find news from Colonial Savings, Crawford & Co., Kubota, North Dallas Bank & Trust Co., Amy Stewart Law, and Communities Foundation of Texas.
MORE
Lantern Pharma cancer
Lantern Pharma Teams Up with National Cancer Institute to Predict Drug Effectiveness on Tumors
by | Oct 7, 2019
This alum of Dallas startup accelerator Health Wildcatters is working with the National Cancer Institute's Developmental Therapeutics Branch on precision research and treatments.
MORE
artificial intelligence
Digital Assist: 5 North Texas Startups Making Their Mark With Artificial Intelligence
by | Apr 25, 2018
AI startups across the U.S. raised a record $1.9 billion in VC funding during the first quarter of 2018. From marketing to health care, here's a look at North Texas companies disrupting industries with AI tech.
MORE